12.38
0.00 (0.00%)
| Penutupan Terdahulu | 12.38 |
| Buka | 11.78 |
| Jumlah Dagangan | 5,739 |
| Purata Dagangan (3B) | 161,333 |
| Modal Pasaran | 7,679,962 |
| Harga / Pendapatan (P/E TTM) | 12.38 |
| Harga / Jualan (P/S) | 1.74 |
| Harga / Buku (P/B) | 0.980 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 15 Jun 2025 - 21 Jun 2025 |
| Margin Keuntungan | 0.02% |
| Margin Operasi (TTM) | -26.46% |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 85.30% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 13.92% |
| Nisbah Semasa (MRQ) | 4.91 |
| Aliran Tunai Operasi (OCF TTM) | -1.33 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -1.22 M |
| Pulangan Atas Aset (ROA TTM) | -0.14% |
| Pulangan Atas Ekuiti (ROE TTM) | 0.01% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (GB) | Bercampur | Bercampur |
| Medical Devices (Global) | Menurun | Menurun | |
| Stok | RUA LIFE SCIENCES PLC ORD 5P | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -0.5 |
| Purata | -0.63 |
Saham Serupa
| Stok | Modal Pasaran | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| RUA LIFE SCIENCES PLC ORD 5P | 8 M | - | 12.38 | 0.980 |
| 0K5E | 765 M | 4.01% | 7.06 | - |
| CREO MEDICAL GROUP PLC ORD GBP0 | 53 M | - | - | 1.22 |
| INTELLIGENT ULTRASOUND GROUP PL | 36 M | - | - | 7.29 |
| NOVACYT S.A. EUR1/15TH (CDI) | 34 M | - | - | 0.600 |
| INSPIRATION HEALTHCARE GROUP PL | 15 M | - | - | 1.13 |
|
RUA Life Sciences PLC is a biomedical polymer technology, components, and medical device company. The company's principal activities comprise exploiting the value of its IP and know-how, medical device contract manufacturing, and development of cardiovascular devices. Its business segments are Royalty and License Income (Biomaterials), Contract Manufacture, Product Development (Vascular), and Product Innovation (Structural Heart). It derives the majority of its revenue from the Contract Manufacture segment. Geographically, it derives the majority of its revenue from the USA and has a presence in Switzerland, Italy, the UK, and Israel. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 59.16% |
| % Dimiliki oleh Institusi | 24.92% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |